India Intensifies Anti-Dumping Probe into Anti-TB Drug Ingredient Imports
India has deepened its anti-dumping investigation into imports of Ethambutol Hydrochloride, an active pharmaceutical ingredient used in anti-TB drugs, from China and Thailand.
The probe, launched by the Directorate General of Trade Remedies (DGTR), follows a petition by Lupin Ltd, a leading domestic pharmaceutical company, alleging that imports were being dumped at unfairly low prices, hurting Indian manufacturers.
- Investigation launched by: Directorate General of Trade Remedies (DGTR)
- Petition filed by: Lupin Ltd, a domestic pharmaceutical company
- Reason for probe: Alleged unfair dumping of Ethambutol Hydrochloride at low prices
No official statement has been released regarding the current status of the investigation.
Author: Ruchika Sharma, Correspondent for the Business Section at Medical Dialogue.
Summary: India intensifies anti-dumping probe into imports of anti-TB drug ingredient.
More News
- Superstar Robbie Williams has designed a chair specifically for 'introverts' – but it will set you back almost £3500
- China’s robot-powered factories turn hi-tech production lines into tourist spots
- Microsoft Azure is down, affecting 365, Xbox, Minecraft, and others | TechCrunch
- 7 basic science discoveries that changed the world
- Nvidia becomes first public company worth $5 trillion | TechCrunch
- The ECHR: legal and political fault lines
- 3I Atlas comet updates: Where is it now, and what scientists are saying
- How Depictions Of Poverty Shaped Our Perception Of Homelessness
- Flight simulator fans revive a classic Boeing 747 cockpit
- Candy Warehouse files for bankruptcy